The Cooper Companies, Inc. (NASDAQ:COO) Shares Acquired by Fisher Asset Management LLC

Fisher Asset Management LLC grew its position in The Cooper Companies, Inc. (NASDAQ:COO) by 100.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 120,868 shares of the medical device company’s stock after purchasing an additional 60,637 shares during the quarter. Fisher Asset Management LLC owned approximately 0.06% of Cooper Companies worth $11,111,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Victory Capital Management Inc. grew its position in shares of Cooper Companies by 23.0% in the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock valued at $435,856,000 after buying an additional 737,726 shares during the last quarter. JPMorgan Chase & Co. grew its position in shares of Cooper Companies by 13.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock valued at $543,979,000 after buying an additional 573,908 shares during the last quarter. Alecta Tjanstepension Omsesidigt purchased a new position in shares of Cooper Companies in the 4th quarter valued at $49,550,000. Swedbank AB grew its position in shares of Cooper Companies by 14.0% in the 4th quarter. Swedbank AB now owns 1,629,602 shares of the medical device company’s stock valued at $149,809,000 after buying an additional 200,000 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Cooper Companies by 11.9% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company’s stock valued at $200,665,000 after buying an additional 194,118 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Up 1.4 %

Shares of NASDAQ:COO opened at $91.65 on Tuesday. The company has a market cap of $18.29 billion, a price-to-earnings ratio of 47.00, a PEG ratio of 2.25 and a beta of 1.00. The firm’s 50-day simple moving average is $92.63 and its 200-day simple moving average is $99.59. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a fifty-two week low of $84.76 and a fifty-two week high of $112.38.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating the consensus estimate of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. During the same quarter last year, the business earned $0.87 earnings per share. The business’s revenue for the quarter was up 9.8% compared to the same quarter last year. As a group, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analysts Set New Price Targets

A number of research analysts recently commented on COO shares. Morgan Stanley dropped their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Friday, December 6th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Wells Fargo & Company raised their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Finally, Citigroup lowered their price objective on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research report on Friday, December 6th. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $117.22.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.